SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-339473
Filing Date
2013-08-19
Accepted
2013-08-19 14:59:27
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d547285d10q.htm 10-Q 637734
2 EX-31.1 d547285dex311.htm EX-31.1 9050
3 EX-31.2 d547285dex312.htm EX-31.2 9034
4 EX-32.1 d547285dex321.htm EX-32.1 4054
5 EX-32.2 d547285dex322.htm EX-32.2 4016
  Complete submission text file 0001193125-13-339473.txt   5295402

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kbio-20130630.xml EX-101.INS 471512
7 XBRL TAXONOMY EXTENSION SCHEMA kbio-20130630.xsd EX-101.SCH 40799
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kbio-20130630_cal.xml EX-101.CAL 48824
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kbio-20130630_def.xml EX-101.DEF 216833
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kbio-20130630_lab.xml EX-101.LAB 311150
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kbio-20130630_pre.xml EX-101.PRE 255387
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 131048050
SIC: 2834 Pharmaceutical Preparations